实性肾脏肿块的CT成像:陷阱与解决方案
本文阐述实性肾脏肿块CT评估中的10个陷阱。薄层非增强CT可确认宏观脂肪以诊断血管平滑肌脂肪瘤;肾细胞癌在非增强CT上可模仿肾囊肿;出血性囊肿可模仿实性病变;双能量CT可在基线准确表征不确定病变而无需召回患者;小内生性囊肿的假强化可用双能量CT或MRI克服;小实性肾脏肿块中20%为良性;低剂量技术可因噪声增加而模拟病变不均匀。
要点
- 薄层非增强CT是确认宏观脂肪和诊断血管平滑肌脂肪瘤的关键。
- 非增强CT均匀病变CT值>70 HU基本可诊断出血性囊肿。
- 双能量CT可通过虚拟非增强、碘叠加或定量碘浓度分析表征不确定病变。
核心结论
- CT仍是肾脏肿块表征的一线影像检查,但存在固有局限性,识别这些陷阱可避免误诊。
研究设计与样本
- 本文为综述,呈现实性肾脏肿块CT评估中的10个陷阱及解决方案,未报告系统检索范围与纳入文献数量。
关键影像表现/征象
- 肾细胞癌在非增强CT上测量<20 HU时可模仿肾囊肿,但通常不均匀且边缘不规则。
- 出血性囊肿在非增强CT上可模拟实性病变,但均匀且测量>70 HU的病变基本可诊断出血性囊肿。
- 非增强CT上测量20-70 HU或增强CT上>20 HU的均匀病变为不确定病变,需进一步评估。
- 小(<3 cm)内生性囊肿常表现为假强化,可模拟肾细胞癌。
- 低剂量技术可能因图像噪声增加而模拟病变不均匀。
诊断标准与关键数值
- 非增强CT薄层扫描确认宏观脂肪以诊断血管平滑肌脂肪瘤。
- 非增强CT均匀病变>70 HU基本诊断出血性囊肿。
- 非增强CT均匀病变20-70 HU或增强CT>20 HU为不确定病变,需进一步评估。
- 小实性肾脏肿块(<4 cm)中20%为良性,主要为无可见脂肪的血管平滑肌脂肪瘤或嗜酸细胞瘤。
临床应用与阅片要点
- 使用薄层非增强CT确认宏观脂肪以诊断血管平滑肌脂肪瘤。
- 非增强CT均匀病变>70 HU可基本诊断出血性囊肿,避免误为实性病变。
- 对非增强CT 20-70 HU或增强CT>20 HU的不确定病变,可采用双能量CT虚拟非增强、碘叠加或定量碘浓度分析在基线表征,无需召回患者。
- 少数低强化肾脏肿块(最常见为乳头状肾细胞癌)在多期CT上呈不确定或缺失强化,需随访、增强超声或MRI进一步表征。
- 小内生性囊肿的假强化可通过双能量CT或MRI克服;低剂量技术模拟的不均匀可通过适当使用迭代重建算法改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Computed tomography (CT) remains the first-line imaging test for the characterisation of renal masses; however, CT has inherent limitations, which if unrecognised, may result in errors. The purpose of this manuscript is to present 10 pitfalls in the CT evaluation of solid renal masses. Thin section non-contrast enhanced CT (NECT) is required to confirm the presence of macroscopic fat and diagnosis of angiomyolipoma (AML). Renal cell carcinoma (RCC) can mimic renal cysts at NECT when measuring <20 HU, but are usually heterogeneous with irregular margins. Haemorrhagic cysts (HC) may simulate solid lesions at NECT; however, a homogeneous lesion measuring >70 HU is essentially diagnostic of HC. Homogeneous lesions measuring 20-70 HU at NECT or >20 HU at contrast-enhanced (CE) CT, are indeterminate, requiring further evaluation. Dual-energy CT (DECT) can accurately characterise these lesions at baseline through virtual NECT, iodine overlay images, or quantitative iodine concentration analysis without recalling the patient. A minority of hypo-enhancing renal masses (most commonly papillary RCC) show indeterminate or absent enhancement at multiphase CT. Follow-up, CE ultrasound or magnetic resonance imaging (MRI) is required to further characterise these lesions. Small (<3 cm) endophytic cysts commonly show pseudo-enhancement, which may simulate RCC; this can be overcome with DECT or MRI. In small (<4 cm) solid renal masses, 20% of lesions are benign, chiefly AML without visible fat or oncocytoma. Low-dose techniques may simulate lesion heterogeneity due to increased image noise, which can be ameliorated through the appropriate use of iterative reconstruction algorithms.
引用
- Krishna S, Murray CA, McInnes MD, et al. CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol. 2017. PMID: 28592361. doi:10.1016/j.crad.2017.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。